- Home
- AKRO vs INTR Comparison
AKRO vs INTR Comparison
Compare AKRO & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- INTR
- Stock Information
- Founded
- AKRO 2017
- INTR 1994
- Country
- AKRO United States
- INTR Brazil
- Employees
- AKRO N/A
- INTR N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- INTR
- Sector
- AKRO Health Care
- INTR
- Exchange
- AKRO Nasdaq
- INTR Nasdaq
- Market Cap
- AKRO 2.8B
- INTR 2.5B
- IPO Year
- AKRO 2019
- INTR N/A
- Fundamental
- Price
- AKRO $39.85
- INTR $7.14
- Analyst Decision
- AKRO Strong Buy
- INTR Buy
- Analyst Count
- AKRO 9
- INTR 4
- Target Price
- AKRO $76.29
- INTR $6.48
- AVG Volume (30 Days)
- AKRO 1.1M
- INTR 2.2M
- Earning Date
- AKRO 05-16-2025
- INTR 05-16-2025
- Dividend Yield
- AKRO N/A
- INTR 1.13%
- EPS Growth
- AKRO N/A
- INTR 176.00
- EPS
- AKRO N/A
- INTR 0.33
- Revenue
- AKRO N/A
- INTR $743,862,312.00
- Revenue This Year
- AKRO N/A
- INTR $84.15
- Revenue Next Year
- AKRO N/A
- INTR $15.63
- P/E Ratio
- AKRO N/A
- INTR $21.12
- Revenue Growth
- AKRO N/A
- INTR 43.28
- 52 Week Low
- AKRO $17.86
- INTR $3.88
- 52 Week High
- AKRO $58.40
- INTR $7.84
- Technical
- Relative Strength Index (RSI)
- AKRO 44.56
- INTR 74.24
- Support Level
- AKRO $41.60
- INTR $6.34
- Resistance Level
- AKRO $46.47
- INTR $7.20
- Average True Range (ATR)
- AKRO 2.26
- INTR 0.23
- MACD
- AKRO 0.08
- INTR 0.05
- Stochastic Oscillator
- AKRO 21.84
- INTR 89.24
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop & Commerce Plus. It generates maximum revenue from the Banking & Spending.